store at low temperature
store at -20°C
Ranibizumab is a humanized monoclonal antibody fragment designed to target and inhibit vascular endothelial growth factor (VEGF), including VEGF110, VEGF121, and VEGF165. Ranibizumab's ability to selectively target and neutralize VEGF-A isoforms has made it a crucial component of research and treatment strategies for wet wet age-related macular degeneration (AMD).
説明 | Ranibizumab is a humanized monoclonal antibody fragment designed to target and inhibit vascular endothelial growth factor (VEGF), including VEGF110, VEGF121, and VEGF165. Ranibizumab's ability to selectively target and neutralize VEGF-A isoforms has made it a crucial component of research and treatment strategies for wet wet age-related macular degeneration (AMD). |
分子量 | 48 kDa |
CAS No. | 347396-82-1 |
store at low temperature
store at -20°C
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ranibizumab 347396-82-1 Angiogenesis Tyrosine Kinase/Adaptors VEGFR VEGF121 Vascular endothelial growth factor receptor AMD RG 6321 VEGF110 Inhibitor inhibit RG6321 RG-6321 anti-VEGF antibody age-related macular degeneration VEGF165 inhibitor